Hjem
Zhanna Gaulens bilde

Zhanna Gaulen

Ph.d.-kandidat
  • E-postzhanna.gaulen@uib.no
  • Besøksadresse
    Haukelandsveien 28
    Armauer Hansens hus
    5009 Bergen
  • Postadresse
    Postboks 7804
    5020 Bergen
Vitenskapelig artikkel
  • Vis forfatter(e) (2021). The Predictive Value of Degree of Preference for Extended-Release Naltrexone for Treatment Adherence, Opioid Use, and Relapse. European Addiction Research. 56-67.
  • Vis forfatter(e) (2021). Risk of Relapse Among Opioid-Dependent Patients Treated With Extended-Release Naltrexone or Buprenorphine-Naloxone: A Randomized Clinical Trial. American Journal on Addictions. 453-460.
  • Vis forfatter(e) (2021). Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up. Journal of Substance Abuse Treatment. 8 sider.
  • Vis forfatter(e) (2019). Beyond medication: Life situation of older patients in opioid maintenance treatment. Addiction Research and Theory.
  • Vis forfatter(e) (2019). Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: Extension of a randomized clinical trial. European Addiction Research. 1-7.
  • Vis forfatter(e) (2017). Health and social issues among older patients in opioid maintenance treatment in Norway. Nordic Studies on Alcohol and Drugs (NAD). 80-90.
  • Vis forfatter(e) (2016). Interest in extended release naltrexone among opioid users. European Addiction Research. 301-305.
  • Vis forfatter(e) (2016). Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX). BMC Pharmacology & Toxicology. 10 sider.
  • Vis forfatter(e) (2016). An overview of youth substance abuse recovery strategies in Norway. Journal of groups in addiction & recovery. 228-239.
Rapport
  • Vis forfatter(e) (2015). Helsemessige og sosiale problemer blant eldre i LAR. .

Se fullstendig oversikt over publikasjoner i CRIStin.